Director/PDMR Shareholding

RNS Number : 9957D

GlaxoSmithKline PLC

12 July 2016

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sir Andrew Witty
b)	Position/status	CEO
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ISIN: GB0009252882
b)	Nature of the transaction	Acquisition of ordinary shares under the Company's ShareReward Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) £16.7127 7 (partnership shares) £16.7127 7 (matching shares)
d)	Aggregated information Aggregated volume Price	14 Ordinary shares £16.7127
e)	Date of the transaction	2016-07-11 (12:18 GMT)
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHQLLFFQDFLBBV